Language Select
Varian Logo

INVESTOR RELATIONS

Our Mission is to Focus Energy on Saving Lives.

Varian Selected to Provide Proton System and Software for Oncology Hospital in South China

PALO ALTO, Calif. and GUANGZHOU, China, Oct. 25, 2017 /PRNewswire/ -- Varian Medical Systems (NYSE: VAR) today announced it has been selected to install a ProBeam® four-room proton therapy system in the new Guangzhou Concord Cancer Hospital. Varian will also provide its Eclipse™ treatment planning and ARIA® oncology information management software for the hospital, in addition to a 10-year service agreement. Varian booked the order in the fourth quarter of its fiscal year 2017.

Guangzhou Concord Cancer Hospital, a subsidiary of Concord Medical Services Holdings Limited, began construction in February 2017, and is scheduled to begin operation in late 2019. When completed, the hospital will be one of the most advanced oncology centers equipped with a proton therapy system in Guangdong province, China. It will feature four proton therapy treatment rooms with full 360 degree rotational gantries.

"We are pleased to be partnering with Varian to equip our facility with advanced equipment and software to create a best-in-class cancer treatment center," said Dr. Jianyu Yang, chairman and chief executive officer of Concord Medical. "When the Guangzhou Concord Cancer Hospital is in service, it will provide high-quality and patient-friendly radiation therapy services for cancer patients throughout China."

"We are very proud to supply the proton therapy solution for Guangzhou Concord Cancer Hospital," said Dr.Moataz Karmalawy, general manager of Varian's Particle Therapy division. "China continues to be a growth region for proton therapy and Varian has invested in resources and infrastructure to ensure the patients in China receive this advanced cancer care."

Varian's ProBeam system is the first to offer fully-integrated intensity-modulated proton therapy (IMPT) to enable more efficient adaptive proton therapy. Varian's pencil-beam scanning technology gives clinicians the ability to deliver the dose precisely within the contours of the tumor to minimize dose to healthy tissue. When combined with integrated cone-beam computed tomography (CBCT), the ProBeam system enables advanced adaptive therapy during the course of treatment helping to make it a more precise form of proton therapy.

About Varian Medical Systems
Varian Medical Systems focuses energy on saving lives and is the world's leading manufacturer of medical devices and software for treating and managing cancer. Headquartered in Palo Alto, California, Varian employs approximately 6,600 people around the world. For more information, visit http://www.varian.com and follow @VarianMedSys on Twitter.

About Concord Medical Holdings Limited
Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2017, the Company operated a network of 60 centers with 41 hospital partners that spanned 34 cities and 19 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

Press Contact

Mark Plungy
Varian Medical Systems
+1 (650) 424-5630
mark.plungy@varian.com

Helen Yang
Varian Medical Systems
+8610 87836354
helen.yang@varian.com

 

SOURCE Varian Medical Systems

  • Follow Us

Production of any of the material contained herein in any format or media without the express written permission of Varian Medical Systems is prohibited.

Varian Logo